• Sab. Lug 27th, 2024

niaid

  • Home
  • NIH-sponsored trial of nasal COVID-19 vaccine opens

NIH-sponsored trial of nasal COVID-19 vaccine opens

A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COVID-19, is…

NIAID: H5N1, il virus nel latte crudo diminuisce con la pastorizzazione. Studio sul New England Journal of Medicine

La quantità di virus influenzali infettivi H5N1 nel latte crudo è rapidamente diminuita con il trattamento termico nelle ricerche di laboratorio condotte dagli scienziati del National Institute of Allergy and…

NIH pubblica il programma di ricerca sull’influenza H5N1

Photo credit NIAID. Tre particelle del virus dell’influenza A (H5N1/ influenza aviaria) (a forma di bastoncino). L’Istituto nazionale per le allergie e le malattie infettive (NIAID), parte del National Institutes…

Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…

Antibody reduces allergic reactions to multiple foods in NIH clinical trial

A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume…

Switching to vegan or ketogenic diet rapidly impacts immune system

Researchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called…